A carregar...

Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy

BACKGROUND: Azilsartan (AZI) is a relatively new angiotensin receptor blocker available for the treatment of any stage of hypertension, which was eventually given in combination with chlorthalidone (CLT). OBJECTIVE: To review pharmacology and clinical role of AZI monotherapy and AZI/CLT or AZI/amlod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Core Evid
Autor principal: Angeloni, Emiliano
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829189/
https://ncbi.nlm.nih.gov/pubmed/27103882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S81776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!